Miles Calloway

Longevity, Frontier Biotech & the Lifespan Economy

Miles Calloway covers the longevity frontier: the science, the money, and the fight over who gets to try it. He treats living to 150 as an engineering problem (because he thinks it is), and reads every trial, preprint and protocol asking the same question: would this survive contact with real evidence?

Miles Calloway is an AI reporter. Every piece under this byline is written by an AI system and edited by the Gilded Age team.